特定亚型的昼夜时钟失调调节乳腺癌生物学,侵袭性和预后
Jan A Hammarlund1, Shi-Yang Li2, Gang Wu3
1School of Biomedical Engineering, Science and Health Systems. Drexel University, Philadelphia, PA, USA.
bioRxiv : the preprint server for biology
|June 9, 2023
概括
乳腺癌中的循环节障碍与特定的亚型有关,这些亚型会影响表皮-介质细胞转换 (EMT) 途径. 这种分子时钟失调会影响转移潜力和患者预后,突出治疗点.
科学领域:
- 分子生物学分子生物学
- 时间生物学 时间生物学
- 在瘤学瘤学.
背景情况:
- 循环节障碍与乳腺癌风险有关,但人类乳腺组织中的分子节奏仍然不太了解.
- 研究人类非癌症和癌症乳腺组织中的分子节奏对于了解乳腺癌的发展和进展至关重要.
研究的目的:
- 研究人类非癌症和癌症乳腺组织中的分子节奏.
- 探索昼夜干扰,上皮层-介质细胞过渡 (EMT) 和乳腺癌预后之间的关系.
主要方法:
- 使用时间标记的活检和公共数据集进行分子节律的信息化重建.
- 对非癌症和各种乳腺癌亚型的昼夜基因表达的分析.
- 评估CYCLOPS大小和EMT途径在光线A瘤中的循环.
主要成果:
- 在非癌性组织中推断的昼夜基因顺序与已知的生理学保持一致,与炎症,EMT和雌激素通路的昼夜调制保持一致.
- 乳腺瘤在昼夜组织中表现出亚型特定的变化.
- 光线A瘤表现出中断但持久的节奏,在高幅度瘤中增加了EMT基因循环.
- 高幅度的Luminal A瘤与5年生存率的降低相关.
- 在3D Luminal A培养中破坏分子时钟减少了入侵.
结论:
- 这项研究揭示了乳腺癌中亚型特定的昼夜干扰,将其与EMT,转移潜力和患者预后联系起来.
- 在Luminal A培养物中分子时钟的破坏减少了入侵,这表明昼夜调节在乳腺癌转移中的作用.
- 这些发现突显了光线A乳腺瘤中全局节律强度 (CYCLOPS大小) 的预后意义.
更多相关视频
06:53Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures
Published on: November 11, 2016
8.4K
10:38Monitoring Cell-autonomous Circadian Clock Rhythms of Gene Expression Using Luciferase Bioluminescence Reporters
Published on: September 27, 2012
22.5K
相关概念视频
Circadian Rhythms and Gene Regulation
4.1K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
93
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
93
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
